M.CaponeG.IanaroA.TenoreG
Lack of capacity, compliance issues, or inability to self-administer topical eye drops were also considered exclusion criteria
Clinical trials show tirzepatide is safe beyond 2 years of continuous use with appropriate monitoring
Safety, tolerability and antiviral activity of the antisense oligonucleotide bepirovirsen in patients with chronic hepatitis B: a phase 2 randomized controlled trial
Initial Course: 48 weekly injections Maintenance: Monthly or as advisedresults vary (Results vary by skin type & lifestyle factors) What to Avoid During Treatment
However, given the results reported in previous studies (2,25,31-33) that used moderate/high doses of vitamin B12, it should be possible to demonstrate the non-inferiority of the oral treatment with this power level